HitGen Inc. (SHA:688222)
23.90
+0.46 (1.96%)
Last updated: Aug 1, 2025
HitGen Revenue
HitGen had revenue of 106.74M CNY in the quarter ending March 31, 2025, a decrease of -0.60%. This brings the company's revenue in the last twelve months to 426.34M, up 4.21% year-over-year. In the year 2024, HitGen had annual revenue of 426.99M with 14.99% growth.
Revenue (ttm)
426.34M
Revenue Growth
+4.21%
P/S Ratio
22.33
Revenue / Employee
882.69K
Employees
483
Market Cap
9.52B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 426.99M | 55.66M | 14.99% |
Dec 31, 2023 | 371.32M | 41.67M | 12.64% |
Dec 31, 2022 | 329.65M | 18.59M | 5.98% |
Dec 31, 2021 | 311.06M | 67.46M | 27.69% |
Dec 31, 2020 | 243.60M | -20.60M | -7.80% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 29.19B |
Shenzhen Mindray Bio-Medical Electronics | 35.59B |
WuXi AppTec | 41.48B |
Sichuan Biokin Pharmaceutical | 5.82B |
Zhangzhou Pientzehuang Pharmaceutical., | 10.76B |
Aier Eye Hospital Group | 21.81B |
Shanghai United Imaging Healthcare | 10.43B |
Yunnan Baiyao Group Co.,Ltd | 40.10B |